A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.
Clinical trial NCT03496870 · COMPLETED
Trial details
- NCT number
- NCT03496870
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-08
- Primary completion
- 2018-07-02
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.